口蹄疫市場規模、シェア、成長分析：ワクチンタイプ別、動物タイプ別、流通チャネル別、地域別 - 産業予測 2025～2032年

口蹄疫市場規模は2023年に32億米ドルと評価され、2024年の34億8,000万米ドルから2032年には68億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.8％で成長する見通しです。

世界の動物用ワクチン市場、特に口蹄疫（FMD）ワクチン市場は、畜産物消費の増加と家畜頭数の増加により、著しい成長を遂げています。環境の変化や世界化によって悪化した家畜伝染病や人獣共通感染症の出現により、世界各国の政府は家畜と家畜の両方に対して厳格な衛生対策を実施するよう促しています。こうした懸念の高まりは、国家経済に深刻な影響を与えかねない人獣共通感染症の発生を防ぐことを目的とした規制の枠組みに反映されています。牛乳、卵、肉などの製品需要の高まりによる投資の増加に伴い、FMDワクチン接種の必要性は、潜在的なアウトブレイクによる経済的損失を軽減するために最重要となっています。しかし、北米や欧州のような地域では、FMDの発生を効果的に抑制し、厳格な動物移動規制によってワクチン接種の必要性を減らしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

口蹄疫市場規模：ワクチンタイプ別& CAGR（2025-2032）

• 市場概要
• 従来のワクチン
  • 水酸化アルミニウムとサポニンベースのワクチン
  • 石油ベースのワクチン
• 緊急ワクチン

口蹄疫市場規模：動物タイプ別& CAGR（2025-2032）

• 市場概要
• 牛
• 羊とヤギ
• 豚
• その他の動物

口蹄疫市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 動物病院・診療所
• 政府機関
• 小売薬局
• オンライン薬局

口蹄疫市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Zoetis（USA）
• MSD Animal Health（USA）
• Elanco Animal Health（USA）
• Ceva Sante Animale（France）
• Virbac（France）
• Indian Immunologicals Limited（India）
• Biogenesis Bago（Argentina）
• FMD Center World Reference Laboratory（UK）
• TAD Pharma GmbH（Germany）
• Vetoquinol（France）
• Phibro Animal Health Corporation（USA）
• Tiankang Bio（China）
• Ringpu Biology（China）
• CAVAC（China）
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna（Italy）
• Korea Animal Health Products Association（Korea）
• CZ Veterinaria（Spain）

結論と提言

FMD Disease Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.84 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global veterinary vaccine market, particularly for Foot-and-Mouth Disease (FMD) vaccines, is witnessing significant growth driven by increased animal product consumption and rising livestock populations. The emergence of livestock and zoonotic diseases, exacerbated by environmental changes and globalization, has prompted governments worldwide to implement stringent health measures for both domestic and livestock animals. This growing concern is reflected in regulatory frameworks aimed at preventing zoonotic outbreaks, which could severely impact national economies. With rising investments due to heightened demand for products like milk, eggs, and meat, the necessity for FMD vaccinations becomes paramount to mitigate financial losses from potential outbreaks. However, regions like North America and Europe have effectively controlled FMD incidents, reducing vaccination needs through strict animal movement regulations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fmd Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fmd Disease Market Segments Analysis

Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fmd Disease Market

The increasing demand for animal protein and dairy products significantly drives the FMD market, as foot-and-mouth disease (FMD) can lead to substantial economic losses within the livestock sector. As consumer preferences pivot towards animal-based nutrition, the necessity to maintain healthy livestock becomes crucial. Outbreaks of FMD can disrupt supply chains, result in culling, and diminish herd productivity, leading to increased urgency for effective vaccines and management strategies. Thus, addressing both FMD outbreaks and the rising demand for livestock products is essential for ensuring food security and stability in the agricultural economy, making it a pivotal factor influencing the FMD market.

Restraints in the Fmd Disease Market

The significant expense associated with FMD vaccines and diagnostic tests poses a considerable limitation on the Foot-and-Mouth Disease (FMD) market, especially in developing nations that boast substantial livestock populations. This financial burden restricts access to essential preventive measures and diagnostic tools, hindering effective management and control of the disease in regions where it is most needed. Consequently, the high costs can deter farmers and livestock owners from investing in vaccination programs, thereby increasing the vulnerability of their herds to outbreaks. As a result, the overall progress in mitigating FMD risks is adversely affected, compromising animal health and agricultural productivity.

Market Trends of the Fmd Disease Market

The FMD (Foot-and-Mouth Disease) market is witnessing a notable trend marked by a surge in demand for vaccines, primarily fueled by heightened awareness and proactive measures taken by governments in developing countries. As these nations strive to combat FMD outbreaks that threaten livestock health and agricultural productivity, investment in vaccination programs has intensified. Additionally, the rise in livestock trade and export activities amplifies the need for effective vaccination strategies, thereby driving market growth. Pharmaceutical companies are responding with innovative vaccine formulations and expanded production capacities, creating a dynamic landscape poised for substantial advancements in FMD prevention and control.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global FMD Disease Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• Conventional vaccines
  • Aluminium hydroxide & saponin-based vaccines
  • Oil-based vaccines
• Emergency vaccines

Global FMD Disease Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Cattle
• Sheep & goat
• Pig
• Other animals

Global FMD Disease Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary hospitals & clinics
• Government institutions
• Retail pharmacies
• Online pharmacies

Global FMD Disease Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMD Center World Reference Laboratory (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAD Pharma GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiankang Bio (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAVAC (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korea Animal Health Products Association (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CZ Veterinaria (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations